Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Ibuprofen for PDA in Extremely Premature Infants
NCT01149564Phase 2Unknown
- Sponsor
- China Medical University Hospital
- Start
- Dec 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by China Medical University Hospital. Primary endpoint: Efficacy and safety in inducing PDA closure at 1 month. Status: unknown.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT01149564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149564.